Cystic Fibrosis Flashcards

1
Q

What type of genetic disease is cystic fibrosis?

A

Cystic fibrosis is an autosomal recessive disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the prevalence of cystic fibrosis in the white population?

A

Cystic fibrosis is the most common genetically inherited disease in the white population, with an incidence of 1 in 2500 newborns.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the underlying abnormality in cystic fibrosis?

A

Cystic fibrosis is characterized by abnormal chloride and bicarbonate transport due to pathogenic mutations in the CF transmembrane conductance regulator (CTFR) gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which chromosome is the CFTR gene located on?

A

The CFTR gene is located on chromosome 7.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do mutations in the CFTR gene contribute to clinical symptoms and signs?

A

Mutations in the CFTR gene lead to the production of abnormally viscous mucus and secretions in the lungs, bile and pancreatic ducts, and intestines. These obstructions in the lumens result in the clinical symptoms and signs of cystic fibrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What investigations can be done for gastro-oesophageal reflux disease (GORD) in cystic fibrosis?

A

Blood tests
Oesophagogastroduodenoscopy (OGD) or upper GI tract endoscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is GORD common in cystic fibrosis?

A

GORD is common in cystic fibrosis and can present with symptoms such as heartburn, regurgitation, dysphagia (stricture/malignancy), oesophagitis, stricture, and Barrett’s oesophagus, which can lead to malignancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the management approach for GORD?

A

Conservative measures: Lifestyle changes such as having smaller meals, chewing food well, leaving 2-3 hours between the last meal and bedtime, raising the head of the bed, avoiding tight-fitting clothing, and avoiding precipitant foods.
Medical management: Proton-pump inhibitors, H2-antagonists (e.g., Famotidine).
Surgical management: Anti-reflux procedures such as fundoplication or Linx procedure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the pancreatic disorders associated with cystic fibrosis?

A

Pancreatic exocrine insufficiency (PEI)
Pancreatitis
Malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is pancreatic exocrine insufficiency (PEI)?

A

Pancreatic exocrine insufficiency is a deficiency of the exocrine pancreatic enzymes, resulting in the inability to properly digest food, leading to malnutrition. It is present in about 2/3 of CF patients and is predominantly characterized by fat malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the symptoms of pancreatic exocrine insufficiency?

A

Steatorrhea: Frequent, bulky, foul-smelling stools that are difficult to flush or float.
Failure to thrive
Weight loss
Deficiency of fat-soluble vitamins (A, D, E, and K), leading to coagulopathy and bleeding tendencies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the treatment for pancreatic exocrine insufficiency?

A

Pancreatic Enzyme Replacement Therapy (PERT) with Creon: Typically, 25,000 units with snacks and 50,000 units with main meals.
Proton-pump inhibitors (PPIs) to reduce gastric acid secretion.
Supplementation of fat-soluble vitamins (A, D, E, and K).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the consequences of progressive pancreatic damage in cystic fibrosis?

A

Progressive pancreatic damage can lead to acute or recurrent pancreatitis. Key markers for pancreatic damage include elevated amylase (3 times the upper limit of normal), urinary amylase, and lipase (considered the gold standard). In cases where blood tests are inconclusive, a CT scan can be performed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does cystic fibrosis affect the endocrine function of the pancreas?

A

Dysfunction of the endocrine pancreas in cystic fibrosis can lead to impaired glucose tolerance and CF-related diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What hepatobiliary diseases are associated with cystic fibrosis?

A

Hepatobiliary diseases associated with cystic fibrosis include cirrhosis, steatosis, gallstones, and cholangiocarcinoma (although rare). Liver failure can also occur, albeit infrequently.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism behind hepatobiliary disease in cystic fibrosis?

A

Defective CFTR function in the liver can result in focal biliary obstruction, leading to focal periportal inflammation and the development of multilobular cirrhosis or biliary cirrhosis. Hepatosplenomegaly, portal hypertension, varices, and upper gastrointestinal bleeding can also occur due to the associated portal hypertension and hypersplenism.

17
Q

What is the prevalence of CF-related liver disease?

A

CF-related liver disease accounts for approximately 2.5% of overall mortality in patients with cystic fibrosis. It is the single most important non-pulmonary cause of death in these patients.

18
Q

At what age is CF-related liver disease typically diagnosed?

A

About 90% of CF-related liver disease cases are diagnosed before the age of 20.

19
Q

What are some laboratory findings associated with CF-related liver disease?

A

CF-related liver disease may be associated with elevated liver enzymes such as AST (aspartate aminotransferase), ALT (alanine aminotransferase), and GGT (gamma-glutamyl transferase). The elevation is typically 1-2.5 times the normal levels.

20
Q

Is cirrhosis more common in males or females with CF-related liver disease?

A

Cirrhosis is more commonly observed in males with CF-related liver disease.

21
Q

How can CF-related liver disease be diagnosed?

A

The diagnosis of CF-related liver disease may involve a combination of factors, including medical history, physical examination to assess signs of chronic liver disease, ultrasound (USS) imaging, Fibroscan (a non-invasive method to assess liver stiffness), and occasionally liver biopsy.

22
Q

What is the treatment option for end-stage CF-related liver disease?

A

In cases of end-stage CF-related liver disease, liver transplantation may be considered. However, it is important to note that post-transplant immunosuppression can increase the risk of cancer development.

23
Q

Who is commonly affected by distal intestinal obstruction syndrome (DIOS)?

A

DIOS is more commonly seen in older children and adults with cystic fibrosis.

24
Q

How would you describe distal intestinal obstruction syndrome (DIOS)?

A

DIOS is a chronic and recurrent form of intestinal obstruction, typically involving partial blockage. It is characterized by thick, adherent intestinal contents obstructing the terminal ileum and proximal colon.

25
Q

What are the diagnostic approaches for DIOS?

A

The diagnosis of DIOS may involve a combination of factors, including medical history, physical examination, abdominal X-ray (AXR), ultrasound (USS), and computed tomography (CT) scans.

26
Q

What are the treatment options for DIOS?

A

The management of DIOS typically includes rehydration, correction of electrolyte abnormalities, and the use of enemas (e.g., gastrograffin enemas). In some cases, laparoscopy may be performed for intraluminal milking and washout to relieve the obstruction.

27
Q

What are the cardinal signs of bowel obstruction?

A

Colicky abdominal pain
Abdominal distension
Nausea/vomiting
Absolute constipation

28
Q

What are the measurements for the diameter of the small bowel, large bowel, and caecum in the context of bowel obstruction?

A

Small bowel: Approximately 3 cm in diameter
Large bowel: Approximately 6 cm in diameter
Caecum: Approximately 9 cm in diameter

29
Q

How does cystic fibrosis increase the risk of gastrointestinal (GI) malignancies?

A

Cystic fibrosis is associated with the upregulation of oncogenic genes and the inflammatory state in the gastrointestinal tract, which promotes oncogenesis. Individuals with cystic fibrosis have an increased risk of GI cancers, including colon cancer (the most common), small bowel cancer, biliary tract cancer, and pancreatic cancer.

30
Q

How is colon cancer screening performed in individuals with cystic fibrosis?

A

Colonoscopic screening for colon cancer typically begins at the age of 40 and is repeated every 5 years. If polyps are detected, more frequent screenings may be recommended (e.g., every 3 years). Symptoms such as anemia, changes in bowel habits, weight loss, and hematochezia (blood in stool) should also be evaluated. Additional diagnostic tools include the use of Faecal Immune Test (FIT), colonoscopy, CT scans, and capsule endoscopy.

31
Q

What are some nutritional considerations for individuals with cystic fibrosis?

A

Pancreatic enzyme replacement therapy (e.g., Creon) to aid in digestion.
Supplementation of fat-soluble vitamins (A, D, E, and K) due to malabsorption.
High-calorie diet to maintain weight and meet increased nutritional needs.
Oral feeding is generally preferred, but enteral feeding through methods like PEG (percutaneous endoscopic gastrostomy) or jejunostomy may be necessary.
In cases where oral or enteral feeding is not feasible or sufficient, parenteral nutrition may be considered.
Individuals with cystic fibrosis have an increased risk of sepsis, so proper infection control measures should be implemented.